Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load - PubMed (original) (raw)
. 2004 Aug 15;104(4):942-7.
doi: 10.1182/blood-2003-09-3333. Epub 2004 Apr 29.
Christina M R Kitchen, Lea Liu, Hua Guo, Ron Gascon, Amy B Narváez, Peter Hunt, Jeffrey N Martin, James O Kahn, Jay Levy, Michael S McGrath, Frederick M Hecht
Affiliations
- PMID: 15117761
- DOI: 10.1182/blood-2003-09-3333
Free article
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
Steven G Deeks et al. Blood. 2004.
Free article
Abstract
Although generalized T-cell activation is an important factor in chronic HIV disease pathogenesis, its role in primary infection remains poorly defined. To investigate the effect of immune activation on T-cell changes in subjects with early HIV infection, and to test the hypothesis that an immunologic activation "set point" is established early in the natural history of HIV disease, a prospective cohort of acutely infected adults was performed. The median density of CD38 molecules on CD4+ and CD8+ T cells was measured longitudinally in 68 antiretroviral-untreated individuals and 83 antiretroviral-treated individuals. At study entry, T-cell activation was positively associated with viremia, with CD8+ T-cell activation levels increasing exponentially at plasma HIV RNA levels more than 10,000 copies/mL. Among untreated patients, the level of CD8+ T-cell activation varied widely among individuals but often remained stable within a given individual. CD8+ T-cell activation and plasma HIV RNA levels over time were independently associated with the rate of CD4+ T-cell loss in untreated individuals. These data indicate that immunologic activation set point is established early in HIV infection, and that this set point determines the rate at which CD4+ T cells are lost over time.
Similar articles
- The independent effect of drug resistance on T cell activation in HIV infection.
Hunt PW, Deeks SG, Bangsberg DR, Moss A, Sinclair E, Liegler T, Bates M, Tsao G, Lampiris H, Hoh R, Martin JN. Hunt PW, et al. AIDS. 2006 Mar 21;20(5):691-9. doi: 10.1097/01.aids.0000216369.30948.18. AIDS. 2006. PMID: 16514299 - Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E, Al Tabaa Y, Baillat V, Segondy M, Picot MC, Reynes J, Vendrell JP. Tuaillon E, et al. Cytometry B Clin Cytom. 2009 Jul;76(4):249-60. doi: 10.1002/cyto.b.20467. Cytometry B Clin Cytom. 2009. PMID: 19072838 - Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V. Benito JM, et al. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81. doi: 10.1097/01.qai.0000153105.42455.c2. J Acquir Immune Defic Syndr. 2005. PMID: 15764953 - HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM, Shepherd ME, Brookmeyer RS, Hon H, Quinn TC, Kashamuka M, Johnson M, Gottle R, Devers J, Lederman HM, Bollinger RC. Lubaki NM, et al. J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):19-30. doi: 10.1097/00042560-199909010-00003. J Acquir Immune Defic Syndr. 1999. PMID: 10534143 - HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.
Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H. Soghoian DZ, et al. Sci Transl Med. 2012 Feb 29;4(123):123ra25. doi: 10.1126/scitranslmed.3003165. Sci Transl Med. 2012. PMID: 22378925 Free PMC article.
Cited by
- Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype.
Marichannegowda MH, Setua S, Bose M, Sanders-Buell E, King D, Zemil M, Wieczorek L, Diaz-Mendez F, Chomont N, Thomas R, Francisco L, Eller LA, Polonis VR, Tovanabutra S, Heredia A, Tagaya Y, Michael NL, Robb ML, Song H. Marichannegowda MH, et al. EBioMedicine. 2024 Oct 19;109:105410. doi: 10.1016/j.ebiom.2024.105410. Online ahead of print. EBioMedicine. 2024. PMID: 39427414 Free PMC article. - The impact of sex on HIV immunopathogenesis and therapeutic interventions.
Mihealsick E, Word A, Scully EP. Mihealsick E, et al. J Clin Invest. 2024 Sep 17;134(18):e180075. doi: 10.1172/JCI180075. J Clin Invest. 2024. PMID: 39286972 Free PMC article. Review. - Human Immunodeficiency Virus-Induced Interferon-Stimulated Gene Expression Is Associated With Monocyte Activation and Predicts Viral Load.
van Pul L, van Dort KA, Girigorie AF, Maurer I, Harskamp AM, Kootstra NA. van Pul L, et al. Open Forum Infect Dis. 2024 Aug 5;11(8):ofae434. doi: 10.1093/ofid/ofae434. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39104769 Free PMC article. - Neuroimmune cell interactions and chronic infections in oral cancers.
D'Silva NJ, Pandiyan P. D'Silva NJ, et al. Front Med (Lausanne). 2024 Jul 10;11:1432398. doi: 10.3389/fmed.2024.1432398. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39050547 Free PMC article. - A novel web-based risk calculator for predicting surgical site infection in HIV-positive facture patients: a multicenter cohort study in China.
Liu B, Wei G, Hu L, Zhang Q. Liu B, et al. Front Cell Infect Microbiol. 2024 Jun 26;14:1408388. doi: 10.3389/fcimb.2024.1408388. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38988810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials